448 related articles for article (PubMed ID: 8093367)
1. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.
Isola J; Weitz S; Visakorpi T; Holli K; Shea R; Khabbaz N; Kallioniemi OP
J Clin Oncol; 1993 Jan; 11(1):36-43. PubMed ID: 8093367
[TBL] [Abstract][Full Text] [Related]
2. Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.
Isola J; Visakorpi T; Holli K; Kallioniemi OP
J Natl Cancer Inst; 1992 Jul; 84(14):1109-14. PubMed ID: 1352359
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin D expression by cancer and stromal cells in breast cancer: an immunohistochemical study of 1348 cases.
Têtu B; Brisson J; Lapointe H; Wang CS; Bernard P; Blanchette C
Breast Cancer Res Treat; 1999 May; 55(2):137-47. PubMed ID: 10481941
[TBL] [Abstract][Full Text] [Related]
4. [Value of immunohistochemical determination of receptors, tissue proteases, tumor suppressor proteins and proliferation markers as prognostic indicators in primary breast carcinoma].
Göhring UJ; Scharl A; Ahr A
Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):177-83. PubMed ID: 8682282
[TBL] [Abstract][Full Text] [Related]
5. MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors.
González-Vela MC; Garijo MF; Fernández F; Val-Bernal JF
Histol Histopathol; 2001 Apr; 16(2):399-406. PubMed ID: 11332695
[TBL] [Abstract][Full Text] [Related]
6. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
Gasparini G; Weidner N; Bevilacqua P; Maluta S; Dalla Palma P; Caffo O; Barbareschi M; Boracchi P; Marubini E; Pozza F
J Clin Oncol; 1994 Mar; 12(3):454-66. PubMed ID: 7509851
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of cathepsin-D expression in female breast cancer.
Aaltonen M; Lipponen P; Kosma VM; Aaltomaa S; Syrjänen K
Anticancer Res; 1995; 15(3):1033-7. PubMed ID: 7645922
[TBL] [Abstract][Full Text] [Related]
8. p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
Silvestrini R; Benini E; Daidone MG; Veneroni S; Boracchi P; Cappelletti V; Di Fronzo G; Veronesi U
J Natl Cancer Inst; 1993 Jun; 85(12):965-70. PubMed ID: 8496982
[TBL] [Abstract][Full Text] [Related]
9. Node negative breast carcinoma: hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators.
Patel DD; Bhatavdekar JM; Chikhlikar PR; Ghosh N; Suthar TP; Shah NG; Mehta RH; Balar DB
J Surg Oncol; 1996 Jun; 62(2):86-92. PubMed ID: 8649046
[TBL] [Abstract][Full Text] [Related]
10. Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.
Gusterson BA; Gelber RD; Goldhirsch A; Price KN; Säve-Söderborgh J; Anbazhagan R; Styles J; Rudenstam CM; Golouh R; Reed R
J Clin Oncol; 1992 Jul; 10(7):1049-56. PubMed ID: 1351538
[TBL] [Abstract][Full Text] [Related]
11. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG
Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401
[TBL] [Abstract][Full Text] [Related]
12. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up.
Toikkanen S; Helin H; Isola J; Joensuu H
J Clin Oncol; 1992 Jul; 10(7):1044-8. PubMed ID: 1351537
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers.
Sjögren S; Inganäs M; Lindgren A; Holmberg L; Bergh J
J Clin Oncol; 1998 Feb; 16(2):462-9. PubMed ID: 9469329
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.
Rudland PS; Platt-Higgins A; Renshaw C; West CR; Winstanley JH; Robertson L; Barraclough R
Cancer Res; 2000 Mar; 60(6):1595-603. PubMed ID: 10749128
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metallothionein in primary invasive breast cancer.
Ioachim E; Tsanou E; Briasoulis E; Batsis Ch; Karavasilis V; Charchanti A; Pavlidis N; Agnantis NJ
Breast; 2003 Apr; 12(2):111-9. PubMed ID: 14659340
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
[TBL] [Abstract][Full Text] [Related]
18. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
[TBL] [Abstract][Full Text] [Related]
19. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.
Thorpe SM; Rochefort H; Garcia M; Freiss G; Christensen IJ; Khalaf S; Paolucci F; Pau B; Rasmussen BB; Rose C
Cancer Res; 1989 Nov; 49(21):6008-14. PubMed ID: 2790815
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin D and prognosis in breast cancer.
Tandon AK; Clark GM; Chamness GC; Chirgwin JM; McGuire WL
N Engl J Med; 1990 Feb; 322(5):297-302. PubMed ID: 2296271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
